esv3829010
- Organism: Homo sapiens
- Study:estd219 (1000 Genomes Consortium Phase 3 Integrated SV)
- Variant Type:inversion
- Method Type:Sequencing
- Submitted on:GRCh37
- Variant Calls:1
- Validation:Not tested
- Clinical Assertions: No
- Region Size:31,987
- Publication(s):1000 Genomes Consortium Phase 3 Integrated SV
Source: NCBI
- Genome View
- Variant Region Details and Evidence
- Validation Information
- Clinical Assertions
- Genotype Information
Genome View
Select assembly:Overlapping variant regions from other studies: 534 SVs from 51 studies. See in: genome view
Overlapping variant regions from other studies: 534 SVs from 51 studies. See in: genome view
Variant Region Placement Information
Variant Region ID | Placement Type | Score | Assembly | Assembly Unit | Reciprocity | Sequence ID | Chr | Start | Stop |
---|---|---|---|---|---|---|---|---|---|
esv3829010 | Remapped | Perfect | GRCh38.p12 | Primary Assembly | First Pass | NC_000003.12 | Chr3 | 2,456,778 (-150, +150) | 2,488,764 (-150, +150) |
esv3829010 | Submitted genomic | GRCh37 (hg19) | Primary Assembly | NC_000003.11 | Chr3 | 2,498,462 (-150, +150) | 2,530,448 (-150, +150) |
Variant Call Information
Variant Call Placement Information
Variant Call ID | Placement Type | Score | HGVS | Assembly | Reciprocity | Sequence ID | Chr | Start | Stop |
---|---|---|---|---|---|---|---|---|---|
essv18167018 | Remapped | Perfect | NC_000003.12:g.(24 56628_2456928)_(24 88614_2488914)inv | GRCh38.p12 | First Pass | NC_000003.12 | Chr3 | 2,456,778 (-150, +150) | 2,488,764 (-150, +150) |
essv18167018 | Submitted genomic | NC_000003.11:g.(24 98312_2498612)_(25 30298_2530598)inv | GRCh37 (hg19) | NC_000003.11 | Chr3 | 2,498,462 (-150, +150) | 2,530,448 (-150, +150) |